# A Study to Assess Sebaceous Gland Changes and Constituents of Sebum (Skin Oil) Induced by Clascoterone 1% Cream in Acne Patients

> **NCT06425900** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **Sun Pharmaceutical Industries Limited** · enrollment: 10 (actual)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** Winlevi (Clascoterone) cream 1%

## Key facts

- **NCT ID:** NCT06425900
- **Lead sponsor:** Sun Pharmaceutical Industries Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-07-01
- **Primary completion:** 2026-03
- **Final completion:** 2026-03
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2026-01-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06425900

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06425900, "A Study to Assess Sebaceous Gland Changes and Constituents of Sebum (Skin Oil) Induced by Clascoterone 1% Cream in Acne Patients". Retrieved via MORVS 2026-10-18 from https://api.morvs.ai/clinical/NCT06425900. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*